These guides include the Glasgow-Blatchford Score (GBS), AIMS65 score, and Rockall score
Clinical trial data consistently show that these medications produce small to moderate improvements in several lipid parameters, with the magnitude of effect varying by specific agent and patient population
This combination can mimic the effects of Qsymia, an FDA-approved extended release formulation of the same medications, but often at a lower cost when prescribed separately
The FDA requires accurate labeling, good manufacturing practices (GMP), and truthful marketing claims
This structure removes the financial pressure to stay at a lower dose when you might benefit from optimization
Treatment rolled out gradually, and before long, competition from a new drug brought the price down by more than two-thirds